FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077008097> ?p ?o ?g. }

• W2077008097 endingPage "347" @default.
• W2077008097 startingPage "347" @default.
• W2077008097 abstract "An epidemiological survey was carried out concerning farmers producing Flammulina velutipes (W.Curt.:Fr.) Singer “Enokitake” from 1972 to 1986 in Nagano prefecture, Japan. Cancer death rates of the farmers were lower than those of the average rate of total Nagano prefecture. Intake of edible mushrooms was suggested as being effective for risk reduction of cancer. This was an ecological study. Next, a case-control study was made to elucidate the relationship between risk reduction of cancer and intake of edible mushrooms on stomach cancer in the same prefecture from 1998 to 2OO2.The odds ratio (OR) of subjects who were practically not ingesting mushrooms at all was 1.00; the OR of those ingesting Hypsizygus marmoreus (Peck) H.E.Bigelow (Bunashimeji) or Pholiota nameko (T.Ito) S.Ito et S.Imai (Nameko) more than once a week was 0.57 and 0.56, respectively. Whereas the OR of subjects taking mushrooms less than once a week was 1.00, the OR of those taking Flammulina velutipes more than three times a week was 0.66, and the OR of those taking Lentinus edodes (Berk.) Singer “Shiitake” more than three times a week was 0.95. It can be concluded that the intake of Hypsizygus marmoreus, Flammulina velutipes, and Pholiota nameko has the possibility of decreasing stomach cancer incidence.Studies on antitumor activities of mushrooms were carried out in the National Cancer Center, Japan. Many antitumor polysaccharides and protein-bounded polysaccharides were isolated from mushrooms.Based on these studies, extracts were made from Hypsizygus marmoreus and Flammulina velutipes, and a preparation called “EEM” (extracts of edible mushrooms) was supplied. Clinical studies of EEM were performed to investigate the effectiveness for cancer patients. Positive effects of EEM were studied on the cachexia of advanced cancer patients in comparison with MPA (methylacetoxyprogestrone). EEM revealed better results than MPA in clinical response, performance status (PS), and quality of life (QOL). Another clinical study was made with a combination therapy of EEM and cancer chemotherapy agents for advanced cancer patients. The clinical response rate, PS, and QOL of the patients treated with combination therapy (EEM and anticancer drugs) were better than those of the patients treated with anticancer drugs alone. The positive effects of EEM were also investigated for a precancerous lesion on the esophageal mucosa. After the patients of grade II of atypical hyperplasia on the esophageal mucosa were administered EEM tablets for 6 months, a positive effect of EEM was found." @default.
• W2077008097 created "2016-06-24" @default.
• W2077008097 creator A5069719265 @default.
• W2077008097 date "2005-01-01" @default.
• W2077008097 modified "2023-10-13" @default.
• W2077008097 title "Cancer Risk Reduction by Intake of Mushrooms and Clinical Studies on EEM" @default.
• W2077008097 doi "https://doi.org/10.1615/intjmedmushrooms.v7.i3.110" @default.
• W2077008097 hasPublicationYear "2005" @default.
• W2077008097 type Work @default.
• W2077008097 sameAs 2077008097 @default.
• W2077008097 citedByCount "4" @default.
• W2077008097 countsByYear W20770080972016 @default.
• W2077008097 countsByYear W20770080972019 @default.
• W2077008097 crossrefType "journal-article" @default.
• W2077008097 hasAuthorship W2077008097A5069719265 @default.
• W2077008097 hasConcept C121608353 @default.
• W2077008097 hasConcept C126322002 @default.
• W2077008097 hasConcept C2776474821 @default.
• W2077008097 hasConcept C2779220235 @default.
• W2077008097 hasConcept C2779454504 @default.
• W2077008097 hasConcept C2780161578 @default.
• W2077008097 hasConcept C31903555 @default.
• W2077008097 hasConcept C71924100 @default.
• W2077008097 hasConcept C86803240 @default.
• W2077008097 hasConceptScore W2077008097C121608353 @default.
• W2077008097 hasConceptScore W2077008097C126322002 @default.
• W2077008097 hasConceptScore W2077008097C2776474821 @default.
• W2077008097 hasConceptScore W2077008097C2779220235 @default.
• W2077008097 hasConceptScore W2077008097C2779454504 @default.
• W2077008097 hasConceptScore W2077008097C2780161578 @default.
• W2077008097 hasConceptScore W2077008097C31903555 @default.
• W2077008097 hasConceptScore W2077008097C71924100 @default.
• W2077008097 hasConceptScore W2077008097C86803240 @default.
• W2077008097 hasLocation W20770080971 @default.
• W2077008097 hasOpenAccess W2077008097 @default.
• W2077008097 hasPrimaryLocation W20770080971 @default.
• W2077008097 hasRelatedWork W2015358231 @default.
• W2077008097 hasRelatedWork W2253182057 @default.
• W2077008097 hasRelatedWork W2348986578 @default.
• W2077008097 hasRelatedWork W2362706823 @default.
• W2077008097 hasRelatedWork W236552572 @default.
• W2077008097 hasRelatedWork W2371542768 @default.
• W2077008097 hasRelatedWork W2383785052 @default.
• W2077008097 hasRelatedWork W2492204074 @default.
• W2077008097 hasRelatedWork W2979572400 @default.
• W2077008097 hasRelatedWork W4247039214 @default.
• W2077008097 isParatext "false" @default.
• W2077008097 isRetracted "false" @default.
• W2077008097 magId "2077008097" @default.
• W2077008097 workType "article" @default.